49 related articles for article (PubMed ID: 36336708)
1. First-trimester noninvasive prenatal diagnosis of seven facioscapulohumeral muscular dystrophy type 1 families using SNP-based amplicon sequencing: An earlier, rapid and safer way.
Fu X; Zhao Z; Kong L; Li S; Li F; Han X; Sun L; Wu D; Wang Y; Kong X
Am J Med Genet A; 2024 Jun; 194(6):e63560. PubMed ID: 38329169
[TBL] [Abstract][Full Text] [Related]
2. A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.
Gatica LV; Rosa AL
Neuromuscul Disord; 2016 Dec; 26(12):844-852. PubMed ID: 27816329
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic contributors to FSHD.
Daxinger L; Tapscott SJ; van der Maarel SM
Curr Opin Genet Dev; 2015 Aug; 33():56-61. PubMed ID: 26356006
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.
Kurashige T; Morino H; Ueno H; Murao T; Watanabe T; Hinoi T; Nishino I; Torii T; Maruyama H
J Hum Genet; 2023 Feb; 68(2):91-95. PubMed ID: 36336708
[TBL] [Abstract][Full Text] [Related]
5. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1.
Sacconi S; Lemmers RJ; Balog J; van der Vliet PJ; Lahaut P; van Nieuwenhuizen MP; Straasheijm KR; Debipersad RD; Vos-Versteeg M; Salviati L; Casarin A; Pegoraro E; Tawil R; Bakker E; Tapscott SJ; Desnuelle C; van der Maarel SM
Am J Hum Genet; 2013 Oct; 93(4):744-51. PubMed ID: 24075187
[TBL] [Abstract][Full Text] [Related]
6. Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model.
de Greef JC; Krom YD; den Hamer B; Snider L; Hiramuki Y; van den Akker RFP; Breslin K; Pakusch M; Salvatori DCF; Slütter B; Tawil R; Blewitt ME; Tapscott SJ; van der Maarel SM
Hum Mol Genet; 2018 Feb; 27(4):716-731. PubMed ID: 29281018
[TBL] [Abstract][Full Text] [Related]
7. Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.
Lemmers RJLF; van der Vliet PJ; Vreijling JP; Henderson D; van der Stoep N; Voermans N; van Engelen B; Baas F; Sacconi S; Tawil R; van der Maarel SM
Hum Mol Genet; 2018 Oct; 27(20):3488-3497. PubMed ID: 30281091
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs.
Zeng W; Chen YY; Newkirk DA; Wu B; Balog J; Kong X; Ball AR; Zanotti S; Tawil R; Hashimoto N; Mortazavi A; van der Maarel SM; Yokomori K
Hum Mutat; 2014 Aug; 35(8):998-1010. PubMed ID: 24838473
[TBL] [Abstract][Full Text] [Related]
9. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4.
Balog J; Thijssen PE; Shadle S; Straasheijm KR; van der Vliet PJ; Krom YD; van den Boogaard ML; de Jong A; F Lemmers RJ; Tawil R; Tapscott SJ; van der Maarel SM
Epigenetics; 2015; 10(12):1133-42. PubMed ID: 26575099
[TBL] [Abstract][Full Text] [Related]
10. [Inpatients with facioscapulohumeral muscular dystrophy in specialized institutions in Japan from 1999 to 2013-Clinical condition changes and causes of death].
Saito T; Kuru S; Takahashi T; Suzuki M; Ogata K
Rinsho Shinkeigaku; 2019 Nov; 59(11):716-722. PubMed ID: 31656262
[TBL] [Abstract][Full Text] [Related]
11. Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.
Yasuda T; Tsuzuki S; Kawazu M; Hayakawa F; Kojima S; Ueno T; Imoto N; Kohsaka S; Kunita A; Doi K; Sakura T; Yujiri T; Kondo E; Fujimaki K; Ueda Y; Aoyama Y; Ohtake S; Takita J; Sai E; Taniwaki M; Kurokawa M; Morishita S; Fukayama M; Kiyoi H; Miyazaki Y; Naoe T; Mano H
Nat Genet; 2016 May; 48(5):569-74. PubMed ID: 27019113
[TBL] [Abstract][Full Text] [Related]
12. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
[TBL] [Abstract][Full Text] [Related]
13. Population-based incidence and prevalence of facioscapulohumeral dystrophy.
Deenen JC; Arnts H; van der Maarel SM; Padberg GW; Verschuuren JJ; Bakker E; Weinreich SS; Verbeek AL; van Engelen BG
Neurology; 2014 Sep; 83(12):1056-9. PubMed ID: 25122204
[TBL] [Abstract][Full Text] [Related]
14. Facioscapulohumeral dystrophy: the path to consensus on pathophysiology.
Tawil R; van der Maarel SM; Tapscott SJ
Skelet Muscle; 2014; 4():12. PubMed ID: 24940479
[TBL] [Abstract][Full Text] [Related]
15. Early-onset facioscapulohumeral muscular dystrophy type 1 with some atypical features.
Dorobek M; van der Maarel SM; Lemmers RJ; Ryniewicz B; Kabzińska D; Frants RR; Gawel M; Walecki J; Hausmanowa-Petrusewicz I
J Child Neurol; 2015 Apr; 30(5):580-7. PubMed ID: 24717985
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]